ArticleJMIR research protocols2025

Evaluating the Efficacy and Safety of 48-Week Low-Dose Dienogest Administration in Patients With Dysmenorrhea Caused by Endometriosis: Protocol for a Randomized, Open-Label, Parallel-Group Trial.

Kyoko Kikuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.